Dupilumab Efficacy and Safety in Severe Atopic Dermatitis in Children under 6 Years of Age: Two Clinical Cases

Dupilumab Efficacy and Safety in Severe Atopic Dermatitis in Children under 6 Years of Age: Two Clinical Cases

Background. Atopic dermatitis (AD) manifests during the first year of life in majority of all cases. The early disease onset is associated with the development of comorbid atopic conditions within the «atopic march» phenomenon. The AD pathogenesis is associated with genetic predisposition, epidermal...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikolay N. Murashkin, Leonid A. Opryatin, Ekaterina S. Pavlova, Roman V. Epishev, Alexandr I. Materikin, Roman A. Ivanov, Alena A. Savelova, Maria A. Leonova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2023-11-01
Series:Вопросы современной педиатрии
Subjects:
children
atopic dermatitis
diagnosis
treatment
dupilumab
polymorbidity
Online Access:https://vsp.spr-journal.ru/jour/article/view/3306
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://vsp.spr-journal.ru/jour/article/view/3306

Similar Items